EB Development Increases Offer Price for Eurobio Scientific Squeeze-Out

EB Development increased its offer price to Eurobio Scientific shareholders as part of a public squeeze-out offer, followed by a mandatory withdrawal of the shares. The update advances the process to change the company’s ownership structure and end its public listing; the article does not specify the revised price or any market reaction.